NFKB1 and melanoma: In vitro studies on human melanomas have shown that pigmented phenotype made melanoma cells resistant to anti-melanoma activity of vitamin D hydroxyderivatives, which was dependent on their inhibition of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activity [411].